Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Search

Emily Cowley Leongini’s Insights

139 total results. Page 10 of 12.

Alerts
California State and Local Cannabis Rules Take Different Paths
August 9, 2017
Alerts
Court Upholds FDA’s Authority to Regulate E-Cigarettes
August 1, 2017
Health Care Counsel Blog
FDA Issues Draft Guidance For Product Identifier Requirements
July 7, 2017
Alerts
Consumer Groups File False Advertising Suit Over ‘100% Natural’ Claim, Alleging Residues in Poultry
July 5, 2017
Alerts
How FDA’s Program Alignment Initiative Will Impact Industries: An Insider’s Perspective
May 26, 2017
News
Emily Leongini Featured in Q&A with Marijuana Business Daily
May 23, 2017
Alerts
Media Investigations into Integrity of Organic Program Growing
May 16, 2017
Alerts
Cannabis Industry Standards: ASTM Considers Filling the Void
February 24, 2017
Health Care Counsel Blog
Recent Drug Company Settlement Highlights Unique Theory of False Claims Act Liability: Failure to Follow Current Good Manufacturing Practices
February 16, 2017
Alerts
Recent Drug Company Settlement Highlights Unique Theory of False Claims Act Liability: Failure to Follow Current Good Manufacturing Practices
February 16, 2017
Alerts
Trump’s 2-for-1 Executive Order, its Impact on FDA, and the Significance of “Significant”
February 10, 2017
Health Care Counsel Blog
FDA Finalizes Guidance on Assessing New Drug Abuse Potential
February 1, 2017

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

Back to Top